Your browser doesn't support javascript.
loading
Immunotherapy for Parkinson's disease.
Schwab, Aaron D; Thurston, Mackenzie J; Machhi, Jatin; Olson, Katherine E; Namminga, Krista L; Gendelman, Howard E; Mosley, R Lee.
  • Schwab AD; Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5110, United States of America.
  • Thurston MJ; Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5110, United States of America.
  • Machhi J; Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5110, United States of America.
  • Olson KE; Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5110, United States of America.
  • Namminga KL; Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5110, United States of America.
  • Gendelman HE; Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5110, United States of America. Electronic address: hegendel@unmc.edu.
  • Mosley RL; Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5110, United States of America.
Neurobiol Dis ; 137: 104760, 2020 04.
Article en En | MEDLINE | ID: mdl-31978602

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Enfermedad de Alzheimer / Inmunoterapia / Inflamación Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Enfermedad de Alzheimer / Inmunoterapia / Inflamación Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article